Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec followed by Platinum-doublet Chemotherapy and Bevacizumab Compared with Platinum-doublet Chemotherapy and Bevacizumab in Women
Sponsored by GOG Foundation, Inc.
Active
$270.2K Funding
7 People
External
Related Topics
clinical trials,
cancer treatment,
immunotherapy,
chemotherapy,
women's health
People
Setsuko Chambers
Principal Investigator (PI)
Obstetrics and Gynecology
﹒Professor
Sonja Velickovic
(CD)
Cancer Center Division
﹒Laboratory Coordinator I
Aradhana Kari
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Carolyn Lane
(CD)
Cancer Center Division
﹒Research Laboratory Manager I
Janiel Cragun
Co-Investigator (COI)
Obstetrics and Gynecology
﹒Associate Professor, Obstetrics and Gynecology - (Clinical Scholar Track)
Mitzi Miranda
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
Angelique Thornton
(CD)
Cancer Center Division
﹒Research Nurse II